Bonnie Hammer
Executive Vice President - Research & Development Invenra Inc.
Seminars
Tuesday 13th October 2026
From Bi to Trispecific Antibodies: Reimagining the Next Generation of ADCs
2:30 pm
- Utilizing bi- and tri-specific matrix screening to rapidly identify optimal antibody pairings
- Exploring B-Body bispecific and T-Body trispecific antibodies that exhibit good killing from in vitro ADC assays across a diverse set of breast cancer cell lines
- Showcasing that multi-target ADCs demonstrate broader and more durable tumor control in vivo, including in drug-resistant cell populations that evade monospecific therapy
